Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Recap: Poseida Therapeutics Q4 Earnings

Poseida Therapeutics (NASDAQ:PSTX) reported its Q4 earnings results on Thursday, March 10, 2022 at 04:00 PM. Here's what investors need to know about the announcement.
byBenzinga Insights
March 10, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

Poseida Therapeutics (NASDAQ:PSTX) reported its Q4 earnings results on Thursday, March 10, 2022 at 04:00 PM.

Here’s what investors need to know about the announcement.

Earnings

Poseida Therapeutics beat estimated earnings by 105.71%, reporting an EPS of $0.02 versus an estimate of $-0.35.

Revenue was down $0.00 from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.06 which was followed by a 3.85% increase in the share price the next day.

Listen to the earnings announcement yourself by clicking here.

To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.

This article was generated by Benzinga’s automated content engine and reviewed by an editor.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

Eagle Bancorp’s Earnings Outlook

By Benzinga Insights
April 19, 1:39 PM
Eagle Bancorp (NASDAQ:EGBN) is set to give its latest quarterly earnings report on Wednesday, 2022-04-20. Here's what investors need to know before the announcement. Analysts estimate that Eagle Bancorp will report an earnings per share (EPS) of $1.07.

EGBN